123 related articles for article (PubMed ID: 24369735)
1. Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer.
Schytte T; Nielsen TB; Brink C; Hansen O
Acta Oncol; 2014 Mar; 53(3):336-41. PubMed ID: 24369735
[TBL] [Abstract][Full Text] [Related]
2. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
[TBL] [Abstract][Full Text] [Related]
3. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
Sanuki-Fujimoto N; Sumi M; Ito Y; Imai A; Kagami Y; Sekine I; Kunitoh H; Ohe Y; Tamura T; Ikeda H
Radiother Oncol; 2009 Jun; 91(3):433-7. PubMed ID: 19167118
[TBL] [Abstract][Full Text] [Related]
4. How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group.
Nyman J; Friesland S; Hallqvist A; Seke M; Bergström S; Thaning L; Lödén B; Sederholm C; Wagenius G
Lung Cancer; 2009 Jul; 65(1):62-7. PubMed ID: 19081652
[TBL] [Abstract][Full Text] [Related]
5. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
6. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
Werner-Wasik M; Swann RS; Bradley J; Graham M; Emami B; Purdy J; Sause W
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):385-90. PubMed ID: 17869017
[TBL] [Abstract][Full Text] [Related]
7. Involved-field radiation therapy for inoperable non small-cell lung cancer.
Rosenzweig KE; Sura S; Jackson A; Yorke E
J Clin Oncol; 2007 Dec; 25(35):5557-61. PubMed ID: 17984185
[TBL] [Abstract][Full Text] [Related]
8. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
9. Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design.
Feng W; Fu XL; Cai XW; Yang HJ; Wu KL; Fan M; Xiang JQ; Zhang YW; Chen HQ
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1100-7. PubMed ID: 24529715
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiotherapy for patients with completely resected pathologic n2 non-small-cell lung cancer: a retrospective analysis.
Mantovani C; Levra NG; Filippi AR; Novello S; Buffoni L; Ragona R; Ricardi U
Clin Lung Cancer; 2013 Mar; 14(2):194-9. PubMed ID: 22885347
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
Chen M; Hayman JA; Ten Haken RK; Tatro D; Fernando S; Kong FM
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):120-6. PubMed ID: 16198503
[TBL] [Abstract][Full Text] [Related]
13. Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients.
Scotti V; Meattini I; Saieva C; Agresti B; de Luca Cardillo C; Bastiani P; Livi L; Mangoni M; Di Cataldo V; Marrazzo L; Rampini A; Cipressi S; Bruni A; Santini P; Biti G
Radiother Oncol; 2010 Jul; 96(1):84-8. PubMed ID: 20541823
[TBL] [Abstract][Full Text] [Related]
14. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
15. The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05).
Ball DL; Fisher RJ; Burmeister BH; Poulsen MG; Graham PH; Penniment MG; Vinod SK; Krawitz HE; Joseph DJ; Wheeler GC; McClure BE
Radiother Oncol; 2013 Mar; 106(3):305-11. PubMed ID: 23333017
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume.
Basaki K; Abe Y; Aoki M; Kondo H; Hatayama Y; Nakaji S
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):449-54. PubMed ID: 16226400
[TBL] [Abstract][Full Text] [Related]
18. High-dose, conventionally fractionated thoracic reirradiation for lung tumors.
Griffioen GH; Dahele M; de Haan PF; van de Ven PM; Slotman BJ; Senan S
Lung Cancer; 2014 Mar; 83(3):356-62. PubMed ID: 24433824
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Ciammella P; Franco P; Mantovani C; Borasio P; Scagliotti GV; Ragona R
Lung Cancer; 2010 Apr; 68(1):72-7. PubMed ID: 19556022
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
